OBI Pharma, Inc. announced the change of internal audit officer. Name, title, and resume of the previous position holder: Neo Chien/Director /Internal audit director, OBI Pharma Inc. Name, title, and resume of the new position holder: Hanna Hsu/Supervisor /Internal audit supervisor, OBI Pharma Inc. Reason for the change: Position adjustment. Effective date: November 6, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
63.3 TWD | +0.32% |
|
-3.36% | -8.79% |
1st Jan change | Capi. | |
---|---|---|
-8.79% | 444M | |
+26.62% | 46.56B | |
+45.38% | 41.67B | |
+0.66% | 41.16B | |
+31.36% | 32.4B | |
+22.09% | 28.18B | |
-6.35% | 28.1B | |
+49.43% | 14.52B | |
+48.33% | 13.74B | |
+3.65% | 12.17B |
- Stock Market
- Equities
- 4174 Stock
- News OBI Pharma, Inc.
- OBI Pharma, Inc. Announces Internal Audit Officer Changes